Is Sionna Therapeutics, Inc. (SION) a Buy, Sell, or Hold?
Sionna Therapeutics, Inc.
NASDAQ:SION
$42.59 USD
-$1.36 (-3.09%)
- Volume
- 275.95K
- Average Volume
- 446.85K
- Market Capitalization
- $1.92B
- P/E Ratio
- -22.07
- Dividend Yield
- 0.00%
- Price Target
- $52.50
- Year High
- $48.45
- Year Low
- $16.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $22.60
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
151
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 4.19M
SION Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
SION Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Thompson Peter A. | director | 2026-07-07 | S-Sale | 44.86 | 2026-07-09 |
| ORBIMED ADVISORS LLC | director | 2026-07-07 | S-Sale | 44.86 | 2026-07-09 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-07-06 | M-Exempt | 6.11 | 2026-07-07 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-07-06 | M-Exempt | 6.11 | 2026-07-07 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-07-06 | S-Sale | 43.5963 | 2026-07-07 |
| Thompson Peter A. | director | 2026-06-30 | S-Sale | 45.5 | 2026-07-02 |
| ORBIMED ADVISORS LLC | director | 2026-06-30 | S-Sale | 45.5 | 2026-07-02 |
| Stelzer Laurie | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Viney Joanne L. | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Thompson Peter A. | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Ruddy Marcella K. | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Resnick Joshua | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Fleming Harold Edward | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Clancy Paul J | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Booth Bruce | director | 2026-06-17 | A-Award | 36.73 | 2026-06-18 |
| Thompson Peter A. | director | 2026-05-27 | S-Sale | 44.49 | 2026-05-29 |
| ORBIMED ADVISORS LLC | director | 2026-05-27 | S-Sale | 44.49 | 2026-05-29 |
| Thompson Peter A. | director | 2026-05-07 | S-Sale | 44.61 | 2026-05-11 |
| Thompson Peter A. | director | 2026-05-08 | S-Sale | 44.58 | 2026-05-11 |
| Thompson Peter A. | director | 2026-05-11 | S-Sale | 46.22 | 2026-05-11 |
| ORBIMED ADVISORS LLC | director | 2026-05-07 | S-Sale | 44.61 | 2026-05-11 |
| ORBIMED ADVISORS LLC | director | 2026-05-08 | S-Sale | 44.58 | 2026-05-11 |
| ORBIMED ADVISORS LLC | director | 2026-05-11 | S-Sale | 46.22 | 2026-05-11 |
| Thompson Peter A. | director | 2026-04-17 | S-Sale | 44.68 | 2026-04-21 |
| Thompson Peter A. | director | 2026-04-18 | S-Sale | 44.52 | 2026-04-21 |
| ORBIMED ADVISORS LLC | director | 2026-04-17 | S-Sale | 44.68 | 2026-04-21 |
| ORBIMED ADVISORS LLC | director | 2026-04-18 | S-Sale | 44.52 | 2026-04-21 |
| Thompson Peter A. | director | 2026-04-14 | S-Sale | 44.51 | 2026-04-16 |
| Thompson Peter A. | director | 2026-04-15 | S-Sale | 44.64 | 2026-04-16 |
| Thompson Peter A. | director | 2026-04-16 | S-Sale | 45.34 | 2026-04-16 |
| ORBIMED ADVISORS LLC | director | 2026-04-14 | S-Sale | 44.51 | 2026-04-16 |
| ORBIMED ADVISORS LLC | director | 2026-04-15 | S-Sale | 44.64 | 2026-04-16 |
| ORBIMED ADVISORS LLC | director | 2026-04-16 | S-Sale | 45.34 | 2026-04-16 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-03-05 | M-Exempt | 6.11 | 2026-03-06 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-03-05 | M-Exempt | 6.11 | 2026-03-06 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-03-05 | S-Sale | 33.8555 | 2026-03-06 |
| Thompson Peter A. | director | 2026-02-02 | S-Sale | 44.57 | 2026-02-04 |
| Thompson Peter A. | director | 2026-02-03 | S-Sale | 44.58 | 2026-02-04 |
| ORBIMED ADVISORS LLC | director | 2026-02-02 | S-Sale | 44.57 | 2026-02-04 |
| ORBIMED ADVISORS LLC | director | 2026-02-03 | S-Sale | 44.58 | 2026-02-04 |
| TPG GP A, LLC | 10 percent owner | 2026-01-22 | S-Sale | 40 | 2026-01-26 |
| McKee Charlotte | officer: Chief Medical Officer | 2026-01-02 | A-Award | 39.21 | 2026-01-06 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2026-01-02 | A-Award | 39.21 | 2026-01-06 |
| Cloonan Michael | director, officer: President & CEO | 2026-01-02 | A-Award | 39.21 | 2026-01-06 |
| Beer Caroline Stark | officer: Chief Business Officer | 2026-01-02 | A-Award | 39.21 | 2026-01-06 |
| Ridloff Elena | officer: CFO | 2026-01-02 | A-Award | 39.21 | 2026-01-06 |
| ORBIMED ADVISORS LLC | director | 2025-12-24 | S-Sale | 44.55 | 2025-12-29 |
| Thompson Peter A. | director | 2025-12-24 | S-Sale | 44.55 | 2025-12-29 |
| ORBIMED ADVISORS LLC | director | 2025-12-17 | S-Sale | 44.5 | 2025-12-19 |
| ORBIMED ADVISORS LLC | director | 2025-12-18 | S-Sale | 44.49 | 2025-12-19 |
| ORBIMED ADVISORS LLC | director | 2025-12-19 | S-Sale | 44.49 | 2025-12-19 |
| Thompson Peter A. | director | 2025-12-17 | S-Sale | 44.5 | 2025-12-19 |
| Thompson Peter A. | director | 2025-12-18 | S-Sale | 44.49 | 2025-12-19 |
| Thompson Peter A. | director | 2025-12-19 | S-Sale | 44.49 | 2025-12-19 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2025-12-05 | M-Exempt | 6.11 | 2025-12-09 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2025-12-05 | M-Exempt | 6.11 | 2025-12-09 |
| Fitzpatrick Jennifer | officer: Chief Legal Officer | 2025-12-05 | S-Sale | 40.52 | 2025-12-09 |
| ORBIMED ADVISORS LLC | director | 2025-11-24 | S-Sale | 44.54 | 2025-11-26 |
| ORBIMED ADVISORS LLC | director | 2025-11-25 | S-Sale | 44.6 | 2025-11-26 |
| ORBIMED ADVISORS LLC | director | 2025-11-26 | S-Sale | 44.49 | 2025-11-26 |
| Thompson Peter A. | director | 2025-11-24 | S-Sale | 44.54 | 2025-11-26 |
| Thompson Peter A. | director | 2025-11-25 | S-Sale | 44.6 | 2025-11-26 |
| Thompson Peter A. | director | 2025-11-26 | S-Sale | 44.49 | 2025-11-26 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 39.89 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 40.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-21 | S-Sale | 39.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 39.89 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 40.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-21 | S-Sale | 39.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 39.89 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 40.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-21 | S-Sale | 39.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 39.89 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-20 | S-Sale | 40.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-21 | S-Sale | 39.5 | 2025-11-24 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 40.2 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 41.05 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 42.1 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-18 | S-Sale | 39.57 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.01 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.61 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 40.2 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 41.05 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 42.1 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-18 | S-Sale | 39.57 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.01 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.61 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 40.2 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 41.05 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 42.1 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-18 | S-Sale | 39.57 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.01 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.61 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 40.2 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 41.05 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-17 | S-Sale | 42.1 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-18 | S-Sale | 39.57 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.01 | 2025-11-19 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-11-19 | S-Sale | 40.61 | 2025-11-19 |